SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

REGOLI, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.181
AS - Asia 5.635
EU - Europa 3.468
SA - Sud America 775
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 9
Totale 23.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.867
SG - Singapore 2.147
CN - Cina 1.489
DE - Germania 861
VN - Vietnam 599
BR - Brasile 584
UA - Ucraina 577
IT - Italia 495
GB - Regno Unito 414
HK - Hong Kong 407
TR - Turchia 367
FI - Finlandia 346
FR - Francia 207
CA - Canada 195
SE - Svezia 153
BD - Bangladesh 146
RU - Federazione Russa 146
JP - Giappone 115
IN - India 114
MX - Messico 67
AR - Argentina 58
PL - Polonia 51
ZA - Sudafrica 47
IQ - Iraq 43
BE - Belgio 42
NL - Olanda 40
ES - Italia 36
PK - Pakistan 36
CO - Colombia 32
LT - Lituania 30
EC - Ecuador 29
ID - Indonesia 29
UZ - Uzbekistan 21
VE - Venezuela 19
MY - Malesia 18
CL - Cile 17
MA - Marocco 16
AE - Emirati Arabi Uniti 15
PH - Filippine 14
SA - Arabia Saudita 13
EG - Egitto 11
JM - Giamaica 11
PE - Perù 11
PY - Paraguay 10
TN - Tunisia 10
AL - Albania 9
AU - Australia 9
UY - Uruguay 9
AT - Austria 8
CR - Costa Rica 8
CZ - Repubblica Ceca 8
BG - Bulgaria 7
IR - Iran 7
JO - Giordania 7
HN - Honduras 6
IL - Israele 6
KE - Kenya 6
LB - Libano 6
SN - Senegal 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
NP - Nepal 5
SV - El Salvador 5
CH - Svizzera 4
ET - Etiopia 4
HR - Croazia 4
KZ - Kazakistan 4
PA - Panama 4
TH - Thailandia 4
BH - Bahrain 3
BO - Bolivia 3
DK - Danimarca 3
HU - Ungheria 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SR - Suriname 3
AM - Armenia 2
AZ - Azerbaigian 2
BJ - Benin 2
CY - Cipro 2
DZ - Algeria 2
EU - Europa 2
GD - Grenada 2
GR - Grecia 2
IE - Irlanda 2
KH - Cambogia 2
KR - Corea 2
MN - Mongolia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
Totale 23.166
Salva come PNG Salva come JPEG
Città #
Ashburn 1.539
Singapore 1.420
Fairfield 1.109
Woodbridge 1.076
San Jose 828
Houston 673
Jacksonville 616
Ann Arbor 559
Chandler 519
Santa Clara 512
Beijing 489
Seattle 422
Hong Kong 403
Wilmington 392
Cambridge 352
Munich 342
Dallas 284
New York 269
Los Angeles 268
Council Bluffs 251
Ho Chi Minh City 199
Izmir 193
Nanjing 178
Helsinki 152
Milan 144
Hanoi 133
Princeton 119
San Diego 113
Tokyo 111
Boardman 100
Lauterbourg 97
Orem 87
Denver 79
Shanghai 78
Brooklyn 72
Turku 71
Montreal 64
São Paulo 63
London 60
Atlanta 58
Nanchang 58
Dearborn 57
Phoenix 57
Toronto 55
Shenyang 51
Frankfurt am Main 46
San Francisco 46
Buffalo 45
Falls Church 44
Chicago 43
Brussels 40
Boston 39
Warsaw 39
Mexico City 35
Bremen 33
Falkenstein 33
Hefei 33
Hebei 32
Tianjin 32
Ferrara 31
Johannesburg 30
Auburn Hills 29
Jiaxing 29
Philadelphia 29
Changsha 28
Da Nang 27
Jinan 27
Mountain View 27
San Mateo 27
Manchester 26
Chennai 23
Mcallen 22
Moscow 22
Norwalk 22
Stockholm 21
Haiphong 20
Redwood City 20
Rio de Janeiro 20
Addison 19
Poplar 19
Tashkent 19
The Dalles 19
Kunming 18
Zhengzhou 18
Baghdad 17
Montréal 17
Amsterdam 16
Mumbai 16
Bexley 15
Curitiba 14
Dhaka 13
Guangzhou 13
Hải Dương 13
Lahore 13
Belo Horizonte 12
Indiana 12
Ningbo 12
Pittsburgh 12
Tappahannock 12
Ankara 11
Totale 16.122
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.253
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 401
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 343
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 326
Effects of vasoactive agents in healthy and diseased human saphenous veins 283
A new selective antagonist of the nociceptin receptor 282
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 277
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 276
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 273
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 272
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 268
A new ligand for the urotensin II receptor 261
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 249
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 248
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 244
Ala scan analogues of HOE 140. Synthesis and biological activities 244
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 240
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 239
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 234
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 233
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 233
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 233
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 230
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 226
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 226
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 226
Pharmacological characterisation of novel kinin B2 receptor ligands 225
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 224
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 224
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 223
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 221
B1 and B2 kinin receptors in various species 218
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 218
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 215
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 215
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 213
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 211
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 209
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 209
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 208
Pharmacological characterization of nociceptin receptor: an in vitro study 208
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 207
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 206
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 205
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 204
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 203
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 202
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 201
Structure-activity study at positions 3 and 4 of human neuropeptide S. 200
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 200
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 198
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 197
Characterization of the human vascular kinin B2 receptor by binding assays. 191
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 190
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 190
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 188
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 188
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 184
Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells 184
Nociceptin/orphanin FQ receptor ligands 183
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 182
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 181
Structure-activity relationship study on human urotensin II 181
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 180
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 177
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 176
ANTAGONISTI DEL RECETTORE UT E LORO USI TERAPEUTICI 175
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 175
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 174
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 171
Pharmacology of nociceptin and its receptor: a novel therapeutic target 171
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 171
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats 168
Characterization of endothelin receptors in the human umbilical artery and vein 168
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 165
Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin 163
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 163
Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT(1) and AT(2) receptors 163
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 163
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 161
Pharmacology of the Kallikrein-Kinin system 161
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 158
Receptors for kinins in the human isolated umbilical vein 157
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 155
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 153
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 151
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 150
Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation 149
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 145
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 144
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 140
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 139
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test 138
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 136
Characterization of the human vascular kinin B2 receptor by binding assays 134
Expression and biological activity of B1 bradykinin receptors in two experimental models of epilepsy 133
Identificazione di un antagonista del recettore UT 131
Pharmacological characterisation of [(pX)Phe(4)]nociceptin(1-13)amide analogues - 1. In vitro studies 129
Identificazione di un agonista parziale del recettore per il neuropeptide S 129
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 126
Totale 21.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.750
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.127 0 0 96 98 87 56 73 72 57 94 123 371
2022/20231.332 125 50 62 168 224 176 112 100 196 7 68 44
2023/2024631 76 78 37 16 39 133 21 42 13 12 14 150
2024/20252.785 54 51 206 106 337 315 133 177 397 244 405 360
2025/20267.580 827 316 632 996 1.142 479 896 341 703 783 310 155
2026/20271.887 1.253 420 214 0 0 0 0 0 0 0 0 0
Totale 23.289